KANATA,
ON, April 18, 2024 /PRNewswire/ -
Today, DRUGDOCS® Inc., a leader in delivering authoritative
drug information to healthcare professionals, announced the rollout
of a significant update to its platform, now featuring advanced AI
integration.
The DRUGDOCS® platform systematically gathers drug-related data
from a variety of sources including clinical study reports,
systematic reviews, meta-analyses, product monographs, and clinical
practice guidelines. This comprehensive approach allows healthcare
providers to access crucial drug information quickly, eliminating
the need for time-consuming independent searches. To guarantee that
the data remains current and reliable, the DRUGDOCS® database is
updated regularly.
DRUGDOCS® introduces its all new AI integration, an advancement
that represents a substantial step forward in the way doctors
use evidence on prescribed drugs for patient care. By weaving
advanced AI into the fabric of the DRUGDOCS® platform, health care
providers have an incredibly powerful tool – a synthesis of the
current evidence on the drugs that they prescribe. Adhering to high
methodological rigor in collecting the evidence, the DRUGDOCS®
database provides a foundation of reliability and trustworthiness
for the AI generated summaries. This ensures that when doctors make
decisions based on the summaries, they're doing so with confidence
and the ability to directly access the primary publications behind
the summaries.
The incorporation of AI into the DRUGDOCS® platform does more
than just update the technology—it reaffirms the company's
commitment to excellence and innovation in healthcare and
underscores its ongoing dedication to the medical community.
"Our AI-driven enhancements are transforming how medical
professionals access and use drug information," said Isabella Steffensen, PhD, CEO of DRUGDOCS® Inc.
"There is simply no other platform that matches the level of
evidence-based solutions provided by DRUGDOCS®."
For further information or media inquiries, please
visit www.drugdocs.com.
About DRUGDOCS® Inc.:
DRUGDOCS® Inc. was founded in 2008 with the mission to empower
healthcare professionals with the latest prescription drug
information to make informed, evidence-based decisions through
unbiased resources that support the highest standard of care.
For more information or media inquiries, please
contact: Dr. Red Thaddeus D.
Miguel, Chief Technical Officer, DRUGDOCS® Inc.,
rmiguel@drugdocs.com, +1-613-271-0566
View original
content:https://www.prnewswire.com/news-releases/drugdocs-launches-enhanced-ai-integrated-platform-at-the-american-college-of-physicians-internal-medicine-meeting-2024-302118578.html
SOURCE DRUGDOCS® Inc.